Elevating the Site-Sponsor Experience: SaaS-Based Safety Notifications for Clinical Trials
February 16th 2022Wednesday, February 16, 2022 at 11am EST Are duplicative and voluminous safety letters from your clinical trials overwhelming investigators and staff? See how the Safety Notifications module of the IQVIA Investigator Site Portal can ease the administrative burden and put the focus back on patient safety in this complimentary webinar from IQVIA Technologies.
Elevating the Site-Sponsor Experience: SaaS-Based Feasibility and Site Selection for Clinical Trials
January 26th 2022Wednesday, January 26, 2022 at 11am EST Are your feasibility assessments repetitious and frustrating for everyone involved? See why sites are already saying they are “highly satisfied” with an all-new Feasibility module from IQVIA Technologies in this complimentary webinar.
Future of RBM: Aligning monitoring of clinical trials with technological and societal evolution
November 30th 2021Tuesday, November 30th, 2021 at 11am EST Current changes in technology and the impact of the COVID pandemic has greatly accelerated the adoption of RBM methodology and AI/ML assisted risk analysis. How are these changing directly impacting your future clinical trials as the industry is reorienting itself around a new normal with regards to monitoring and insights provided by integrated data reviews.
Making Every Connection Count- IQVIA Connected Devices powers clinical trials with better data
November 2nd 2021Tuesday, November 2, 2021 at 11am EDT Get treatments to patients faster and deliver a better experience for both patients and clinical trial sites. Join IQVIA leaders Jeff Noll and Sara Pawley and learn how IQVIA matches the right connected device for each study protocol to enhance data quality, speed data collection, and accelerate trial outcomes.
Investigator Payments – A Critical Component in Bayer’s Sponsor of Choice Strategy
July 20th 2021Tuesday, July 20, 2021 at 11am EDT It’s not often that a sponsor calls a clinical trial solution “life-changing,” but that’s how Bayer is describing the impact of IQVIA Clinical Trial Payments as the solution rolls out to more than 20 countries. Learn how it’s possible to pay sites 2-3 times faster, eliminate end-of-study reconciliation, and reduce time spent supporting payment processes by up to 90%.
How Cloud Technologies are Enabling the Decentralization of Clinical Trials
May 19th 2021*** Wednesday, May 19, 2021 at 12pm EDT *** Join partners IQVIA Technologies and Salesforce for this webinar where we explore a new paradigm in life sciences where virtualization of clinical trials, both for patients and sites, has become a reality, and why it has become the industry’s new technological imperative. ***On demand available after final airing until May 19, 2022***
Through Obstacles and Beyond: The Value of Building Strategic Site Relationships
May 4th 2021*** Wednesday, May 4, 2021 at 11am EDT *** Driving faster site activation for any clinical trial requires close interactions with sponsors to seamlessly execute a breadth of requirements to stay compliant while delivering to new levels of efficiencies ***On demand available after final airing until May 4, 2022***
Trials and Tribulations of Electronic Patient Consent: Removing Barriers to eConsent Adoption
April 28th 2021*** Wednesday, April 28, 2021 at 11am EDT *** After a decade of dabbling with eConsent, it’s time for sponsors and technology providers to meet the demand to bring clinical trials directly to the patient at a global scale. Join this webinar to learn how to overcome the persistent challenges in eConsent adoption and deliver the promise of decentralized trials. ***On demand available after final airing until Apr. 28, 2022***
Clinical Development of Oncology Products in Japan – the 2nd Largest Market for Innovation
November 19th 2020*** Thursday, November 19, 2020 | 4:00 pm-5:00 pm EST ***Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. In addition, the Japanese market is driven by ongoing regulatory and government initiatives that reward innovation, shifts in population demographics, and increased disease awareness, and identifiable patient populations, amongst other factors. ***On demand available after final airing until Nov. 19, 2021***
Use of RWE in Clinical Development to Enhance Regulatory Submission
April 7th 2020Learn more about global regulatory acceptance of real-world evidence in a regulatory submission. Understand how to identify opportunities to incorporate real-world Evidence in your submission package. Live: Tuesday, Apr. 7, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Apr. 7, 2021. Register free
Benchmark Your Clinical Development Plans and Drive Better Clinical Strategy
January 30th 2020Enter a new era of clinical development planning. Use the power of “big data” and machine learning to generate more accurate plans that embrace uncertainty. Learn how to improve your development planning strategy while reducing trial costs and durations. Live: Thursday, Jan. 30, 2020 at 11am EST | 10am PST | 4pm GMT | 5pm CET On demand available after airing until Jan. 30, 2021. Register free
Transforming Regulatory Affairs: Sharing Industry Peer Perspectives
December 10th 2019Regulatory requirements continually change, requiring the use of new innovative approaches, including technology advancement and process automation. Join us and take advantage of lessons learned from your peers to eliminate bottlenecks and leverage up-to-date regulatory intelligence to mitigate risks. Live: Tuesday, Dec. 10, 2019 at 11am EST On demand available after airing until Dec. 10, 2020. Register free